Goto

Collaborating Authors

 mtnn


Alternate Training of Shared and Task-Specific Parameters for Multi-Task Neural Networks

arXiv.org Artificial Intelligence

This paper introduces novel alternate training procedures for hard-parameter sharing Multi-Task Neural Networks (MTNNs). Traditional MTNN training faces challenges in managing conflicting loss gradients, often yielding sub-optimal performance. The proposed alternate training method updates shared and task-specific weights alternately, exploiting the multi-head architecture of the model. This approach reduces computational costs, enhances training regularization, and improves generalization. Convergence properties similar to those of the classical stochastic gradient method are established. Empirical experiments demonstrate delayed overfitting, improved prediction, and reduced computational demands. In summary, our alternate training procedures offer a promising advancement for the training of hard-parameter sharing MTNNs.


Massively Multitask Networks for Drug Discovery

arXiv.org Machine Learning

Massively multitask neural architectures provide a learning framework for drug discovery that synthesizes information from many distinct biological sources. To train these architectures at scale, we gather large amounts of data from public sources to create a dataset of nearly 40 million measurements across more than 200 biological targets. We investigate several aspects of the multitask framework by performing a series of empirical studies and obtain some interesting results: (1) massively multitask networks obtain predictive accuracies significantly better than single-task methods, (2) the predictive power of multitask networks improves as additional tasks and data are added, (3) the total amount of data and the total number of tasks both contribute significantly to multitask improvement, and (4) multitask networks afford limited transferability to tasks not in the training set. Our results underscore the need for greater data sharing and further algorithmic innovation to accelerate the drug discovery process.